Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Drug Development Newsletter 6-26-2019, CGC/CURR CURE Pharmaceutical & Canopy Growth to Produce CBD Oral Thin Films
(Micro-cap gets GLOBAL DISTRIBUTION agreement, building on its LICENSING agreement, with a Large Cap...do the math. Can you say Q3/Q4!))
CURE Pharmaceutical recently announced it is collaborating with Canopy Growth Corporation to develop a new low-dose cannabidiol (CBD) oral thin film (OTF) using CURE’s patented CUREfilm technology for global distribution. This CUREfilm license gives Canopy a dosage form that is ideal for administering cannabinoids.
“This collaboration builds on our licensing agreement with Canopy and accelerates product commercialization,” said Rob Davidson, CEO of CURE Pharmaceutical. “We will leverage our recent patented developments in cannabis-based drug delivery, to formulate an oral thin film product for optimal efficacy and dosing frequency.”
CURE is registered with the US Drug Enforcement Agency (DEA) to develop and manufacture cannabis-derived and synthetic cannabinoid-based products using its CUREfilm technology at its facility in Oxnard, CA. With CUREfilm, the delivery of cannabinoids is easier and more effective as it offers increased bioavailability, ease and precision of dosing, and greater palatability.
CURE Pharmaceutical is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has a full-service cGMP manufacturing facility and is a pioneering developer and manufacturer of a patented and proprietary delivery system (CUREfilm), one of the most advanced oral thin film on the market today. CURE is developing an array of products in innovative delivery platforms and partners with biotech and pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the US, Canada, and Israel. The company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced. For more information, visit www.curepharma.com.
I love a 12-follower IHub up and coming company! With very significant weekly news upcoming. And a listing!!!
if its anything like prior annual meetings, there are only a few non-company attendees... about a half-dozen or so.
Buy the Gold Mine, OR buy the Miner's Suppliers? On June 19th, CGC was listed on the PR from CURR. CURR's technology will be vital to the launch of CGC's consumer products. There is a range of products they have been working on for CGC since Q3 of 2018. They will be launched shortly (Q3, or Q4). Those launches will help to cut margin losses at CGC. They will be a booster rocket for CURR. CGC is not the only customer of CURR. The beauty of dealing with large and growing companies like CGC, is that once they are broadly owned and followed, that there will be long periods where they are in share price limbo as the markets settle out. While that happens, the smaller, and often, critical suppliers to these market elephants, are getting carried by the waves of market growth. Leverage the knowledge you have about the critical need for margin expansion. Additional acreage is a commodity margin...CGC requires added margin to enhance its competitive position. If they don't get it by year-end 2019, they will begin their decline. Buy the mine, or the miner?
NurOwn I believe is licensed from an Israeli University?? Kern came from Big Pharma to BCLI.
No, no reason to believe that. As BCLI gets further along in testing, the evidence of efficacy will increase, so its either great, good, or poor. If its poor, then no reason for Ralph to hang around. He's my litmus test for holding the shares...
Will be interested in learning when you have added to, or changed your position. Agree with your perspective. My view is that with tiny micro-caps that when 'key-man' changes happen, that there are normally fundamental issues that caused their departures...normally negative, either financial, production, or development related. I think someone like Ralph, is the key-man in this show, and would likely reflect development-side issues. I am hopeful that he sees this through to a productive conclusion.
Videos are useful for validation purposes, rationale for holding onto the stock while we wait, a long, long time, for results to come in. Without these videos for support, I would have left this party by now. If, as you say, the MS efforts are funded for the time being, then that is certainly further cause to hold on. Ralph Kern is the main reason to be invested. If he ever leaves.....don't hesitate, just sell!!!!
New Hire? Guy worked <2 years at most of his prior gigs, in project management. Hope he is a good hands on engineer ... if that is what they are looking for. Someone to make sure the t's are crossed and i's dotted for filings not to get screwed up.
Thurman Maynard Nurown on UTube. Watch it.
CURR begins its commercial journey with this announcement. Each piece of upcoming news will be focused on products planned with new partners, production efforts to get product rolled off its factory lines and to retail markets, and JVs with BP and others for development...hopefully with milestones/royalties attached. And a NASDAQ listing in near future. This should be much higher priced 4-6 weeks from now.
Then, unless there is some news out, PPS goes down from here with a raise. No need to increase a position until after the next round is completed...
Do they need funding for MS development/trials? ALZ was well funded through grants...I'm not sure if the same type of support has been made available for MS. And, perhaps they have other indications in mind for development and trials as well, so needing of funding. Chaim would not want to dilute unless he absolutely had to do it. Until now they've been pretty financially clean, and I hope it stays that way.....we will see between now and year end.
Absolutely atrocious management here. So much potential if they JV'd, partnered with a serious company(ies). Management, Ben Locke, has a 'forever' micro-cap mentality. They need to bring in a strong management consulting team and listen to their recommendations. They have huge potential, but have been taking baby steps for more than 3 years. Absolutely inexcusable by now.
This situation does not pass the smell test. Very scary right here. I hope Management is clean.
Huge raise, losing tons of money, <$4.75, on the way to $3's...maybe$2's. lots of downside still, smokey, not anywhere near safe to enter here.
$7.67...<$7 soon? We will be seeing some very low numbers here....
well run company! hold for the long term...
Down on good news? There is heavy selling pressure coming from somewhere?
To get to $1 Billion:
Okay on healthy share structure. Check.
The High Side Market Maker on the Ask. Huh??
Patent news. Yes. But what is that worth over the next 2-3 years? $10M, $50M, $100M? You're saying its worth $1Billion?? Why, How?
Volume shift is probably likely and could bump us a double....but any more than that has to be backed up by the real world.
Not seeing a $1 Billion market cap without heavy, heavy, use of their CBD.
Really? $33 is what you think it's worth? Its now $4.00 with $122M market cap. Company has $0 sales, but you think its worth $1 Billion?
Wondering how you are so confident. Care to provide your logic?
From $5 to a yearly low. $1.33 $5M Raise. Anyone know who might have been part of the raise? Idiots bought at $5. Were these idiots, or geniuses, who bought at $1.33?????????????
Nothing to keep this at this level unless they put out some news. Could easily drop <$7 with zero communication. Need some customer engagements....trials....anything!!
Why has this been dropping like a rock from $7? Relentless over the past 4 weeks..what gives?
How does a President do an Insider Buy 2 days before a major partnership is announced? Is he somehow immune from SEC regulations?
Second, the Bitcoin deal will probably not start before end of Q4 2019, per the PR, ie. lucky to place the 1st unit. How do they "scale up" to 150-200 units during 2020? Are they out-of-their-minds???????????????
So far, they are screwing up everything they have touched. Need a new Management Team, FAST.
No way to run a company!
Thanks to all for identifying and alerting the company. Yes, they need to read their own filings, or else get a refund from their attorneys. Really Bush League!! Very embarrassing for their Management!!
Thank you. I thought on the recent CC that a different agency/person was handling the call.
No idea where the 50% increase in share count came from. The Yahoo market cap is way!!! off. Doesn't this require an SEC filing, and isn't this is regulation violation? Perhaps they have more time to report this change? I can't tell who their current PR company is. It seems to keep changing.
Had not seen this. Thanks for posting. Good to see the investigator so enthused. Looks very promising, and I think that the eventual results from PH2 MS will be equally strong. I don't recall when those results are out. Who knows when they announce a third target indication. This should be at least double from here if not more in 2019. 2020 will be quite a show, assuming similar results to what the videos reflect. I hope more video evidence is forthcoming over the Internet, such as Matt's progress and the 13 folks that begin treatments in Israel.
Thank you for posting this. Hope it is true. They should be able to create some groundswell in other international ALS organizations for a Right to Try there as well.
The Hospital Exemption Program in Israel is an excellent start. It was easily predicted to begin there with this model, but the company was extremely closed lipped about it. Hoping that Canada (Brazil?) and other countries might be willing to duplicate the model. You'll never hear it from BCLI until the news is formally issued via PR.
Very much staying on-track. Fingers crossed that the medical procedures work as intended. We'll know a lot more within 3 months time. if so, $10+ within 24 months is within reason. 5x today's price works for me.
Per October 29, expected raise in Q1. Was $5 at that time, and the raise will probably be done in low $5. AH price about $5.50. They will probably need to do additional raises. I think we still could see this in the $3's. Wouldn't touch this until smoke clears. They have a lot to prove while they burn through their funding.
20x avg volume, ended up 20%, $1.74. Getting some recognition for its upside potential. Hope it stays above $2 as of February.
Volume last week, and since mid-December spiked considerably. Appears that institution(s) are taking an interest here. Don't believe that they are giving up anything this early in the game. Chaim is willing to assume more risk here, but perhaps he's getting funding to do the MS work and that is becoming known, OR they have another indication that they will soon announce. They are clearly getting additional backing as their science gets moved further downfield and is proving itself. Its going to get stronger respect/higher share price over the next 12 months.
? BCLI discussion on Fannie Mae Board??
HJLI is a potential 500% return over next 24 months. Now $1.40 12-26-18, $7 in 2020. At a minimum. Good mgt, good products being put into test, quality partners, huge markets, big potential buyout. Market Cap only $18M.
super buy if it gets hit by the overall market down at $4.10-$4.25. A $10 stock by 2020 at a minimum.
Ok. I have no idea how this company intersects with BCLI share structure. All I know is that Chaim is 100% committed to BCLI at this time. Looking at their website, it may not be updated since 2013, so who knows what the situation is. However, under the Real Estate tab, if they still do own 15% of all real estate in Astoria Queens, Chaim is now much, much wealthier man. Amazon is moving into that neighborhood.
wrong board
Absolutely no idea. If I had to guess, they may have received confirmation of funding by a/the key MS Societies. They'd probably announce beginning January with additional detail around the program. Hope they get a PR splash on that. They need and deserve to.